Skip to main content
ALLIANCE PHARMA PLC logo

ALLIANCE PHARMA PLC — Investor Relations & Filings

Ticker · APH ISIN · GB0031030819 LEI · 213800RYIWZA4Q5WPZ13 IL Wholesale and retail trade
Open in API
Filings indexed 492 across all filing types
Latest filing 2021-12-29 Share Issue/Capital Cha…
Country GB United Kingdom
Listing IL APH

About ALLIANCE PHARMA PLC

https://www.alliancepharmaceuticals.com/

Alliance Pharma PLC is an international specialty pharmaceutical company with a primary focus on consumer healthcare. The company's business model is centered on the acquisition, licensing, and marketing of a portfolio of consumer health products and prescription medicines. It operates globally, investing in its key brands to empower consumers to improve their health and wellbeing. A core part of its strategy is the ongoing development to become a high-performing consumer healthcare company.

Recent filings

Filing Released Lang Actions
Block Listing Six Monthly Return
Share Issue/Capital Change Classification · 99% confidence The document begins with 'RNS Number : 9410W' and is dated '29 December 2021'. The content details a 'Block Listing Six Monthly Return' covering the period from June 28, 2021, to December 28, 2021. It specifically tracks the balance of unallotted securities under various share option plans. This type of filing, which reports on the status of securities reserved for employee share schemes, is a routine regulatory disclosure often submitted to the exchange (like the LSE via RNS). Since it is a specific regulatory filing that doesn't fit the definitions for 10-K, ER, IR, or DIRS, and it is a formal announcement published via RNS, the most appropriate general category for routine regulatory updates that aren't covered by more specific codes (like DVA or DIV) is RNS (Regulatory Filings). Although it relates to capital/shares, it is a compliance return rather than a primary capital change announcement (SHA/CAP). Given the RNS header and the nature of the return, RNS is the best fit.
2021-12-29 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a notification released via RNS (the news service of the London Stock Exchange) and explicitly references the UK Financial Conduct Authority's Disclosure and Transparency Rule 5.6.1. The content details the 'Total Voting Rights' as of a specific date (30 November 2021), stating the total number of issued ordinary shares and the corresponding total number of voting rights. This type of mandatory disclosure regarding the total share capital and voting rights is a specific regulatory filing requirement, but it does not fit neatly into the defined categories like 10-K, ER, or DIV. Since it is a formal regulatory announcement that doesn't match a more specific code (like DIRS for insider trading or MRQ for major shareholding changes), the most appropriate classification is the general regulatory filing fallback category, RNS.
2021-12-01 English
Director’s Dealing
Director's Dealing Classification · 100% confidence The document explicitly states it is a 'Director's Dealing' announcement concerning the Chief Executive Officer, Peter Butterfield, exercising options and selling shares. It includes detailed tables required for regulatory disclosure regarding transactions by persons discharging managerial responsibilities (PDMRs) under UK Market Abuse Regulation. This directly corresponds to the definition of Director's Dealing (DIRS). Although it is distributed via RNS, the specific content dictates the DIRS classification over the general RNS fallback.
2021-11-22 English
Update on Interim Dividend Timetable
Notice of Dividend Amount Classification · 98% confidence The document is identified by the 'RNS Number' header and explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' This strongly suggests it is a regulatory announcement. The content specifically details an 'Update on interim dividend timetable,' including changes to the record date and confirming the payment date. This action directly corresponds to the definition of a 'Notice of Dividend Amount' (DIV). Although it is an RNS filing, the specific nature of the announcement (dividend timetable change) makes DIV the most precise classification over the general RNS fallback.
2021-11-09 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official notification released via RNS (RNS Number : 9301Q) from Alliance Pharma PLC, dated November 1, 2021. The content explicitly states it is a notification 'in accordance with the UK Financial Conduct Authority's Disclosure and Transparency Rule 5.6.1' regarding the 'Total Voting Rights' and the total number of issued shares. This type of mandatory disclosure regarding the total number of voting rights, which shareholders use for determining notification thresholds, is a specific regulatory filing. While it relates to share capital, it is not a formal share issue announcement (SHA) or a transaction in own shares (POS). It is a routine regulatory update concerning ownership transparency. Since it is a specific regulatory announcement that doesn't fit the other precise categories (like ER, 10-K, DIV), the most appropriate classification is the general regulatory filing category, RNS, as it is explicitly distributed through the RNS system and concerns compliance with FCA transparency rules.
2021-11-01 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a short notification released via RNS (London Stock Exchange's news service) on October 4, 2021. The content explicitly states the 'Total Voting Rights' as of September 30, 2021, referencing the FCA's Disclosure and Transparency Rule 5.6.1. This type of mandatory disclosure regarding the total number of shares and voting rights is a standard regulatory announcement. Since it is a short, specific regulatory update that doesn't fit into the detailed categories like 10-K, ER, or DIV, it falls best under the general 'Regulatory Filings' (RNS) category, which serves as a fallback for miscellaneous regulatory announcements. It is not a declaration of voting results (DVA) but a statement of the denominator used for voting rights calculations.
2021-10-04 English

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.